U.S. Distribution Challenges with Covid-19 Booster Vaccines
Supply Chain Matters reflects on reports of distribution challenges of updated Covid-19 booster vaccines amid a surge in vaccination needs across the country.
by Bob Ferrari 
United States to Invest $2.7 Billion in Domestic Vaccine Supply Chain
The Supply Chain Matters blog highlights the Biden Administration plans to invest $2.7 billion into domestic supply network capabilities of essential vaccine components
by Bob Ferrari
Breaking- President Biden Announces Accelerated U.S. Vaccine Supply
The Supply Chain Matters blog highlights breaking news indicating that President Joe Biden has indicated that the United States will have enough COVID-19 vaccine supply for all American adults by the end of May.
by Bob Ferrari 
Johnson and Johnson COVID-19 Vaccine Expected to Gain U.S. Approval
The Supply Chain Matters blog highlights the near U.S. approval of the third available COVID-19 vaccine for vaccination supply and use.
by Bob Ferrari
Insightful Reads- COVID 19 Vaccine and Apple Supply Network Challenges
The Supply Chain Matters blog provides reference to three insightful reports addressing both the ongoing COViD-19 vaccine production ramp-up, as well as Apple’s successes in managing its China based outsourced supply network.
by Bob Ferrari
COVID Vaccine and Administration Planning- The Voice of Supply Chain Sounds So Good
The Supply Chain Matters blog reflects on last week’s White House COVID Response Task Force briefing televised nationally where the long awaited voice of the end-to-end supply chain made its presence.
by Bob Ferrari
Daunting Challenges: COVID-19 Vaccine Production, Logistics and Administration
In this abbreviated Supply Chain Matters COVID-19 Healthcare Supply Chain Disruption News Capsule we address the latest developments related to current concerns related to global availability of COVID-19 vaccine supply.
by Bob Ferrari
COVID-19 Vaccine Distribution Begins Across the United States
The Supply Chain Matters blog notes this weekend’s historic milestone in the United states, namely the first doses of approved COVID-19 vaccine making their journey to vaccinate high priority healthcare and first responder professionals.
by Bob Ferrari
News of Pfizer COVID-19 Vaccine Production Cutback- Reality of Concurrent Demand and Supply Network Processes
The Supply Chain Matters blog provides an added update to news that the Pfizer COVID-19 vaccine incurred a temporary production setback for 2020 because of raw material supply chain challenges.
by Bob Ferrari
COVID-19 Multi-Industry Supply Chain Disruption News Capsule- November 16 2020
The Supply Chain Matters blog provides a weekly capsule of news reports that have implications for various industry supply chains. With COVID-19 coronavirus news once again on the rise, we provide this feature to assist our readers in their efforts to keep updated on noteworthy developments.
by Bob Ferrari 
SUSTAINING SPONSORS
